Updates are available Correction dated 2025-01-24
Click to view Correction: https://doi.org/10.1186/s13045-025-01663-9
-
Authors
Hose, Dirk
Ray, Seemun
Rößler, Sina
Thormann, Ulrich
Schnettler, Reinhard
de Veirman, Kim
El Khassawna, Thaqif
Heiss, Christian
Hild, Anne
Zahner, Daniel
Alagboso, Francisca
Henss, Anja
Beck, Susanne
Emde-Rajaratnam, Martina
Burhenne, Jürgen
Bamberger, Juliane
Menu, Eline
de Bruyne, Elke
Gelinsky, Michael
Kampschulte, Marian
Rohnke, Marcus
Wenisch, Sabine
Vanderkerken, Karin
Hanke, Thomas
Seckinger, Anja
Alt, Volker
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SFB/TRR79)
Universitätsklinikum Regensburg
- License Information
-
More Information
Article History
Received: 19 September 2024
Accepted: 13 November 2024
First Online: 18 December 2024
Change Date: 24 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13045-025-01663-9
Declarations
:
: Bone marrow samples: Myeloma patients were included in the study approved by the ethics committee of the Medical Faculty of the University of Heidelberg (#S-152/2010) after written informed consent. 5T33-myeloma mouse model: Animal housing and experimental procedures were realized according to the Institutional Animal Care and Use Committee of the Vrije Universiteit Brussels (license number. LA1230281) and all procedures were approved by the Ethics Committee for Animal Experiments (#15-281-6). Rat model: Animal housing and experimental procedures were performed in full compliance with the institutional and German protection laws after approval by the local animal welfare committee (reference number: V54-19 c20/15-F 31/38).
: Not applicable.
: The authors declare no competing interests.
